Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool to unravel the link between chronic pain and smoking

NCT ID NCT07673926

Knowledge-focused Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study adapts the Pain and Smoking Inventory (PSI) for Turkish-speaking adults who have chronic pain and smoke daily. Researchers will test whether the translated version is reliable and accurate by comparing it with other measures of pain and nicotine dependence. The goal is to create a validated tool to better understand how pain influences smoking habits and vice versa.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a reliable tool to measure how pain and smoking affect each other in Turkish-speaking populations, aiding future research and treatment.
What could go wrong
This is an observational validation study, not a treatment trial. The inventory may not capture all cultural nuances, and results may not generalize beyond Turkish speakers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients aged 18 and older who present to the outpatient clinic with chronic musculoskeletal or systemic pain and are also daily cigarette smokers. The sample will be selected from individuals who are being followed up or treated at a state hospital. It includes individuals from various sociodemographic backgrounds who meet the specific pain duration and smoking quantity criteria, representing a clinical sample of smoking chronic pain patients in Turkey.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years and older. * Having a diagnosis of chronic pain that has persisted for at least 3 months. * Smoking at least 5 cigarettes per day (within the last 30 days). * Being able to read and write in Turkish. * Volunteering to participate in the study and signing the written informed consent form. Exclusion Criteria: * Having a diagnosis of active psychosis or severe depression. * Having a diagnosis of cognitive impairment or intellectual disability. * Having severe alcohol dependence or substance use disorder. * Having reading and writing difficulties to a degree that prevents completing the questionnaire independently. * Being in the pregnancy or breastfeeding period. * Using nicotine replacement therapy or smoking cessation medication within the last 1 month.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bingol University Faculty of Physical Therapy and Rehabilitation

    Bingoel, Turkey (Türkiye)

  • Bingöl State Hospital

    Bingoel, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.